These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Hormone therapy and cardiovascular risk].
    Author: Wütschert R, Cirafici P.
    Journal: Praxis (Bern 1994); 2000 Jun 29; 89(25-26):1090-7. PubMed ID: 11367591.
    Abstract:
    Oral contraception, hormonal replacement therapy and hormonal therapy in cancer patients are commonly used in everyday practice. Venous and arterial thromboembolisms which are potentially fatal are among the most serious side effects experienced by women. In this review, we focus on the circulation, describing the hormonal alterations on hemostasis. The risk of thromboembolic event is discussed in relation with the different hormonal regimen. We will finally propose recommendations for oral contraception in presence of venous or cardiovascular risk factors.
    [Abstract] [Full Text] [Related] [New Search]